Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
199 hedge funds and large institutions have $2.12B invested in Silk Road Medical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 7 closing their positions.
2,639% more call options, than puts
Call options by funds: $7.67M | Put options by funds: $280K
743% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 7
64% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 45
35% more funds holding
Funds holding: 147 → 199 (+52)
26% more capital invested
Capital invested by funds: $1.69B → $2.12B (+$431M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$27.3M |
| 2 |
Millennium Management
New York
|
+$26.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$24.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$13.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$55.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$47.7M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$35.2M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$21.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
201
Stifel Financial
St. Louis,
Missouri
| – | -$622K | -13,821 | Closed |
|
|
AI
202
Atom Investors
Austin,
Texas
| – | -$312K | -6,928 | Closed |
|
203
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$219K | -4,879 | Closed |
|
|
HGERS
204
Householder Group Estate & Retirement Specialist
Scottsdale,
Arizona
| – | +$341 | +7 | New |
|
SILK Hedge Fund Activity: Q4 2022 in Review
199 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2022, worth a combined $2.12B — up 26% from $1.69B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new SILK positions and 7 closed out — a net gain of 52 holders — while 74 added to existing stakes and 45 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $55.5M.
- 199 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2022, up from 147 in Q3 2022.
- Funds reported $2.12B of Silk Road Medical, Inc. Common Stock stock for Q4 2022, up 26% quarter-over-quarter.
- 59 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2022 and 7 closed out, a net change of +52 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2022 was Lord, Abbett & Co, an estimated $27.3M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q4 2022 was Deerfield Management, an estimated $55.5M sold.
Based on aggregated 13F filings for Q4 2022.